Global Human rotavirus vaccine market, By type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, others), End Users (Hospitals and Clinics, Academic and Research, Others), Application (Hospitals and Clinics, Academic and Research), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Human Rotavirus Vaccine Market
The human rotavirus vaccine market is expected to witness market growth at a rate of 11.21% in the forecast period of 2021 to 2028. Data Bridge Market Research report on human rotavirus vaccine market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the production of the vaccines is escalating the growth of human rotavirus vaccine market.
Rotavirus vaccine is applied to prevent against rotavirus infections which can cause severe diarrhoea amongst young children. Symptoms of rotavirus infection consist of severe diarrhoea, vomiting, fever, and abdominal pain which can cause the disease. Rotavirus vaccine is given by mouth and requires two or three doses starting around six weeks of age.
Major factors that are expected to boost the growth of the human rotavirus vaccine market in the forecast period are the rise in the development, the upsurge in the number of immunity-compromised people and the increase in the alertness amongst the people. Furthermore, the rise in the elderly population and the increasing of the general population and live births are couple of factors further propelling the growth of the human rotavirus vaccine market.
On the other hand, the decrease in the healthcare expenses in the advancing countries, the rise in the prices of the vaccines and the adverse reactions and side effects of the vaccine are further estimated to further derail the growth of the human rotavirus vaccine market in the near future.
This human rotavirus vaccine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the human rotavirus vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Human Rotavirus Vaccine Market Scope and Market Size
The human rotavirus vaccine market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the human rotavirus vaccine market is segmented into rotarix, rotateq, rotavac, rotavin-M1, Lanzhou lamb, others.
- On the basis of application, the human rotavirus vaccine market is segmented into Hospitals and Clinics, Academic and Research
- On the basis of end users, the human rotavirus vaccine market is segmented into hospitals and clinics, academic and research, others.
Human Rotavirus Vaccine Market Country Level Analysis
The human rotavirus vaccine market is analysed and market size insights and trends are provided by country, type, application and end user as referenced above.
The countries covered in the human rotavirus vaccine market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Americas dominates the human rotavirus vaccine market due to the widespread utilization of medications and increase in the expenses on the health care. Furthermore, the rapid uptake of new technology and the focus of main research companies and vaccine research sector in the advanced economies will further boost the growth of the human rotavirus vaccine market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the human rotavirus vaccine market due to the rise in the healthcare expenses. Moreover, the upsurge in the disposable income and the initiatives taken by the government is further anticipated to propel the growth of the human rotavirus vaccine market in the region in the coming years.
The country section of the human rotavirus vaccine market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The human rotavirus vaccine market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for human rotavirus vaccine market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the human rotavirus vaccine market. The data is available for historic period 2010-2019.
Competitive Landscape and Human Rotavirus Vaccine Market Share Analysis
The human rotavirus vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to human rotavirus vaccine market.
The major players covered in the human rotavirus vaccine market report are Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-